Contribution of Psychological Autopsy to the Understanding of Suicidal Behaviors in French Overseas Territories
Launched by UNIVERSITY HOSPITAL CENTER OF MARTINIQUE · Mar 7, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on understanding the reasons behind suicidal behaviors in certain French overseas territories, including French Polynesia, La Réunion, French Guiana, and Martinique. Researchers aim to find common risk factors for suicide by comparing these areas to Amiens, a city in mainland France. They will use a method called "psychological autopsy," which involves interviews with people who knew the deceased well, helping to gather detailed information about their lives and mental health.
To participate in the study, individuals must be at least 18 years old and have known someone who has died by suicide, ideally having knowledge of their childhood. Participants will be interviewed about their experiences and thoughts related to the person's life and struggles. It's important to note that individuals with certain mental health conditions that might affect their ability to provide clear information, or those who do not wish to participate, will not be eligible for this study. This research aims to improve our understanding of suicide and potentially help in developing better prevention strategies.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Persons close of the deceased
- • Persons who knew about his/her childhood
- • Age 18 or over
- • Interviewed for the study between 2 and 11 months after the suicide
- Exclusion Criteria:
- • People with neuropsychiatric disorders that may affect the quality of the information collected, cognitive (memory and expression) and judgmental functions
- • People who refuses to participate
- • Persons referred to articles L.1121-6, L.1121-7, L. 1121-8 L.1121-1-2 of the French Public Health Code.
About University Hospital Center Of Martinique
The University Hospital Center of Martinique (CHUM) is a leading healthcare institution dedicated to advancing medical research and improving patient care through innovative clinical trials. As a prominent academic hospital, CHUM integrates cutting-edge research with clinical practice, fostering collaborations among healthcare professionals, researchers, and academic partners. The center is committed to enhancing health outcomes in the Caribbean region by focusing on a diverse range of medical disciplines, ensuring the highest standards of ethical conduct and patient safety in all trials. Through its comprehensive approach, CHUM aims to contribute significantly to medical knowledge and the development of effective treatment options for various health conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Fort De France, France, Martinique
Patients applied
Trial Officials
STEPHANE AMADEO, Pr
Principal Investigator
University hospital, Martinique
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials